Madrigal Pharmaceuticals (NASDAQ: MDGL) is a biopharmaceutical company focused on developing and commercializing therapies for liver diseases. The filing excerpts provided do not contain sufficient detail to describe Madrigal's revenue model, product portfolio, competitive position, financial metrics, geographic footprint, leadership, or founding history with the specificity required by these writing rules.

Source: SEC 10-K, filed 2026-02-19

Industry: Pharmaceutical Preparations Peers: Vericel Corp Arcutis Biotherapeutics Inc Avid Bioservices, Inc. Avidity Biosciences, Inc. Emergent BioSolutions Inc Enanta Pharmaceuticals Inc Gossamer Bio Inc ImmunoGen, Inc. Sana Biotechnology Inc